Epithelioid Haemangioendothelioma (EHE) is an indiscriminate and often destructive cancer occurring in men or woman at any age and which is often aggressive in children and young adults. We know little about this rare cancer which is why research is so critical. Yet because of its rarity, there is no funding from government or the pharmaceutical industry for research into this cancer, and very little from larger cancer foundations and charities.